RhoGAM is a pharmaceutical-grade, sterile injectable solution containing IgG antibodies to the Rho(D) antigen (D antigen). It is a systemic clinical intervention used to prevent Rh isoimmunization, a condition where an Rh-negative individual develops localized antibodies against Rh-positive blood cells. This specialized localized treatment provides a stable clinical tool for protecting current and future pregnancies, clearing the path for systemic maternal-fetal safety in the Nigerian medical environment.
RhoGAM is a pharmaceutical-grade, sterile injectable solution containing IgG antibodies to the Rho(D) antigen (D antigen). It is a systemic clinical intervention used to prevent Rh isoimmunization, a condition where an Rh-negative individual develops localized antibodies against Rh-positive blood cells. This specialized localized treatment provides a stable clinical tool for protecting current and future pregnancies, clearing the path for systemic maternal-fetal safety in the Nigerian medical environment.
Active Ingredient: Rho(D) Immune Globulin (Human) 300 $\mu$g (1500 IU)
Drug Class: Immunizing Agent (Passive) / Immune Globulin
Formulation: Sterile solution in a pre-filled syringe
Route: Intramuscular (IM) or Intravenous (IV) Injection
Pack Size: Single-dose pre-filled syringe
Availability: Prescription-Only Medicine (POM) — Strict clinical administration required.
Kedrion Biopharma / Ortho Clinical Diagnostics — Produced under stringent systemic ultra-filtration standards to ensure localized viral safety, molecular stability, and the removal of systemic plasma proteins.
RhoGAM is primarily indicated for the systemic prevention of Rh hemolytic disease of the newborn. It is clinically used in Rh-negative women who are pregnant with an Rh-positive fetus to clear the path for preventing the mother's localized immune system from attacking the baby's systemic red blood cells. It is also systemically indicated after localized clinical events such as miscarriage, ectopic pregnancy, or abdominal trauma, as well as for the systemic management of Rh-incompatible localized blood transfusions.
Blood Type Verification: Before systemic administration, the patient must be confirmed as Rh(D) negative and the localized clinical status of sensitization must be verified via a systemic antibody screen.
Hypersensitivity: RhoGAM contains localized human plasma components. Discontinue systemic use immediately if you experience localized hives, systemic chest tightness, or clinical signs of anaphylaxis.
IgA Deficiency: Patients with localized systemic IgA deficiency have an unstable clinical risk of severe allergic reactions; use with extreme localized caution.
Hemolysis Monitoring: When used systemically for localized ITP or transfusion accidents, monitor the patient for clinical signs of systemic intravascular hemolysis and localized kidney strain.
RhoGAM must be systemically administered by a localized healthcare professional. The clinical dose is typically given at 28 weeks of pregnancy and again within 72 hours after delivery if the baby is Rh-positive. For localized clinical events like miscarriage or trauma, the systemic dose should be administered as soon as possible. The injection is given systemically into the localized muscle (IM) or via a slow localized intravenous (IV) infusion to clear the path for immediate systemic protection.
Commonly reported effects include localized soreness, systemic redness, or localized swelling at the clinical injection site. Some patients may experience a systemic mild fever or localized muscle aches. These are often localized clinical signs of the systemic immune response. Consult your doctor if you experience localized persistent back pain, systemic dark urine, or an unstable clinical state of localized shaking or chills.
Store between 2°C and 8°C (Refrigerate; Do Not Freeze). In the Nigerian climate, localized heat will systemically destroy the delicate antibodies; a stable clinical "cold chain" must be maintained from the pharmacy to the clinical site. Keep the localized syringe in its original systemic carton to protect it from light. Keep out of reach of children.
Q: Why do I need it if my localized blood is Rh-negative? A: To clear the path for preventing your systemic immune system from making localized antibodies that could harm your current or future systemic pregnancies.
Q: Is RhoGAM systemically safe for the baby? A: Yes. It is clinically designed to clear the path for the baby’s safety by neutralizing localized Rh-positive cells in the mother's systemic circulation before her immune system reacts.
Q: Does one localized dose protect me forever? A: No. RhoGAM provides systemic passive immunity that is localized to the specific clinical event; it must be systemically repeated for every localized pregnancy or Rh-exposure event.
Q: Can I get it at Sanlive Pharmacy without a prescription? A: No. Due to the systemic requirement for blood grouping and localized clinical monitoring, a valid doctor's prescription and clinical supervision are mandatory.
RhoGAM Injection is a Prescription-Only Medicine. A valid doctor's prescription and blood group report are required. Our licensed pharmacists are available to provide guidance on localized cold-chain transport and systemic safety.
Authentic Biologics: We guarantee 100% original RhoGAM with verified systemic purity and localized NAFDAC registration.
Cold-Chain Integrity: We use professional medical refrigeration to protect the systemic molecular stability of antibodies from the Nigerian heat.
Expert Support: Access to licensed pharmacists for guidance on managing localized clinical timing and systemic administration safety.
Fast Delivery: Reliable and temperature-controlled shipping of essential maternal treatments nationwide across Nigeria.
Order RhoGAM IV Injection from Sanlive Pharmacy for maternal safety and fast delivery.
No reviews yet — be the first!
Log in to write a review.
Welcome back! Sign in to continue.
Join Sanlive Pharmacy — fast, affordable healthcare delivery.